Call Start: 09:00 January 1, 0000 10:05 AM ET Dr. Reddy's Laboratories Limited (NYSE:RDY) Q2 2023 Earnings Conference Call October 28, 2022 09:00 ET Company Participants Amit Agarwal - Head of Investor Relations & Director of Finance Parag Agarwal - Chief Financial Officer Erez Israeli - Chief Executive Officer Conference Call Participants Tarang Agarwal - Old Bridge Capital Prakash Agarwal - Axis Capital Kunal Dhamesha - Macquarie Capital Damayanti Kerai - HSBC Surya Patra - Philip Capital Sameer Baisiwala ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ______ DR. REDDY'S LABORATORIES LIMITED (Translation of registrant's name into English) 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India +91-40-49002900 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40 ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q1 2023 Earnings Conference Call July 28, 2022 9:00 AM ET Company Participants Amit Agarwal - Head of Investor Relations and Director of Finance Parag Agarwal - Chief Financial Officer Erez Israeli - Chief Executive Officer Conference Call Participants Saion Mukherjee - Nomura Anubhav Aggarwal - Credit Suisse Damayanti Kerai - HSBC Prakash Agarwal - Axis Capital Neha Manpuria - Bank of America Sameer Baisiwala - Morgan Stanley Surya Patra - Philip Capital Tarang A ...

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16 OR 15D-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934 June, 2022 Commission File Number 1-15182 DR. REDDY'S LABORATORIES LIMITED (Translation of registrant's name into English) 8-2-337, Road No. 3, Banjara Hills Hyderabad, Telangana 500 034, India +91-40-49002900 (Address of principal executive office) Indicate by check mark whether the registrant files or will file annual reports under ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 | ¨ | | --- | --- | | OR | | | þ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the Fiscal Year Ended March 31, 2022 | | | OR | | | ¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | OR | | | ¨ SHELL COMPANY REPORT PURSUANT TO SECTION 13 O ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q4 2022 Earnings Conference Call May 19, 2022 8:00 AM ET Company Participants Amit Agarwal - Head of Investor Relations and Director of Finance Gunupati Prasad - Co-Chairman & Managing Director Erez Israeli - Chief Executive Officer Parag Agarwal - Chief Financial Officer Conference Call Participants Kunal Dhamesha - Macquarie Neha Manpuria - Bank of America Surya Patra - Philip Capital Nikhil Mathur - HDFC Mutual Fund Prakash Agarwal - Axis Capital Sameer Baisiwa ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q3 2022 Earnings Conference Call January 28, 2022 8:30 AM ET Company Participants Erez Israeli – Chief Executive Officer Amit Agarwal – Head of Investor Relations and FP&A Parag Agarwal – Chief Financial Officer Conference Call Participants Kunal Dhamesha – Emkay Global Neha Manpuria – JPMorgan Damayanti Kerai – HSBC Securities and Capital Markets Surya Putra – Phillip Capital Ashwini Agarwal – Ashmore Investment Sameer Baisiwala – Morgan Stanley Shyam Srinivasan ...

Dr. Reddy's Laboratories Limited (NYSE:RDY) Q1 2021 Earnings Conference Call July 27, 2021 8:00 AM ET Company Participants Amit Agarwal - Head, Investor Relations & Director, Finance, FP&A & Investor Relations Erez Israeli - Chief Executive Officer Parag Agarwal - Chief Financial Officer Conference Call Participants Tushar Manudhane - Motilal Oswal Financial Services Damayanti Kerai - HSBC Securities and Capital Markets Prakash Agarwal - Axis Capital Sriraam Rathi - ICICI Securities Nithya Balasubramanian - ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 20-F | ¨ | REGISTRATION STATEMENT PURSUANT TO SECTION 12(b) OR (g) OF THE SECURITIES EXCHANGE ACT OF 1934 | | --- | --- | | | OR | | þ | ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | For the Fiscal Year Ended March 31, 2021 | | | OR | | ¨ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 | | | OR | | ¨ | SHELL COMPANY REPORT PURSUANT TO SECTION 13 ...

Dr.Reddy's Laboratories Ltd (NYSE:RDY) Q4 2021 Earnings Conference Call May 14, 2021 8:00 AM ET Company Participants Amit Agarwal - Head, IR & Director, Finance, FP&A & IR G.V. Prasad - Co-Chairman & MD Parag Agarwal - CFO Erez Israeli - CEO Conference Call Participants Prakash Agarwal - Axis Capital Limited Damayanti Kerai - HSBC Kunal Dhamesha - Emkay Global Neha Manpuria - JPMorgan Chase & Co. Sameer Baisiwala - Morgan Stanley Nikhil Mathur - AMBIT Capital Ranvir Singh - Sunidhi Securities Shyam Srinivas ...